A Ventas-managed open-ended US life science and healthcare-related real estate fund currently has a $2.4bn (€2.2bn) investment value.

Real estate investment trust Ventas, which holds a $595m investment in the Ventas Life Science & Healthcare Real Estate Fund, disclosed in its 2023 first-quarter earnings report that the fund has a 2.9m sqft portfolio of 13 properties.

Rhode Island Employees Retirement System disclosed in a recent meeting document that it issued a $27m commitment to the Vestas fund through the pension fund’s core real estate portfolio.

Rhode Island Employees said it also made a non-core real estate investment via a $20.6m commitment to Greystar Equity Partners XI.

Partners XI, Greystar’s eleventh value-add real estate fund, is seeking to raise $2.5bn, according to SEC filing. Greystar raised $2bn in 2019 for its tenth fund.

Greystar has an investment history in apartments of buying properties at attractive values, improving property management and implementing capital improvements.

To read the latest edition of the latest IPE Real Assets magazine click here.

Topics